158 related articles for article (PubMed ID: 10603189)
1. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
[TBL] [Abstract][Full Text] [Related]
2. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
3. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
4. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
5. Validation of AutoPap primary screening system sensitivity and high-risk performance.
Tench WD
Acta Cytol; 2002; 46(2):296-302. PubMed ID: 11917576
[TBL] [Abstract][Full Text] [Related]
6. Comparative sensitivities of ThinPrep and Papanicolaou smear for adenocarcinoma in situ (AIS) and combined AIS/high-grade squamous intraepithelial lesion (HSIL): comparison with HSIL.
Roberts JM; Thurloe JK
Cancer; 2007 Dec; 111(6):482-6. PubMed ID: 17969065
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
8. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
9. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
Bibbo M; Hawthorne C; Zimmerman B
Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation.
Wilbur DC; Bonfiglio TA; Rutkowski MA; Atkison KM; Richart RM; Lee JS; Patten SF
Acta Cytol; 1996; 40(1):127-32. PubMed ID: 8604565
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
12. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
[TBL] [Abstract][Full Text] [Related]
13. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
14. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
15. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
[TBL] [Abstract][Full Text] [Related]
16. Atypical endocervical glandular cells: accuracy of cytologic diagnosis.
Lee KR; Manna EA; St John T
Diagn Cytopathol; 1995 Oct; 13(3):202-8. PubMed ID: 8575278
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
18. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
Narkcham S; Mody DR; Jones A; Thrall MJ
J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
Ince U; Aydin O; Peker O
Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]